Search Results - "Parente, Diego Pérez"

Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain by Isla, Dolores, Lopez-Brea, Marta, Espinosa, María, Arrabal, Natalia, Pérez-Parente, Diego, Carcedo, David, Bernabé-Caro, Reyes

“…Atezolizumab has recently been approved for first-line treatment of high PD-L1 expression metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with no EGFR…”
Get full text

PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis by Majem, Margarita, Cobo, Manuel, Isla, Dolores, Marquez-Medina, Diego, Rodriguez-Abreu, Delvys, Casal-Rubio, Joaquín, Bueno, Teresa Moran, Bernabé-Caro, Reyes, Parente, Diego Pérez, Ruiz-Gracia, Pedro, Arroyo, Marta Marina, Paz-Ares, Luis

“…Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selection of patients more likely to respond to immunotherapy and as a…”
Get full text

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer by Provencio-Pulla, Mariano, Pérez-Parente, Diego, Olson, Sara, Hasan, Haroon, Balea, Begoña Campos, Rodríguez-Abreu, Delvys, Piqueras, Marta López-Brea, Pal, Navdeep, Wilkinson, Samantha, Vilas, Esther, Ruiz-Gracia, Pedro, Cobo-Dols, Manuel

“…Introduction Lung cancer is one of the most prevalent cancers and the leading cause of cancer death. Advanced non-small cell lung cancer (aNSCLC) patients…”
Get full text

"High Tumor Burden" in Metastatic Non-Small Cell Lung Cancer: Defining the Concept by Higuera Gómez, Oliver, Moreno Paul, Amaia, Ortega Granados, Ana Laura, Ros Martínez, Silverio, Pérez Parente, Diego, Ruiz Gracia, Pedro, Sáenz Cuervo-Arango, Lucía, Vilà, Laia

“…Identifying patient characteristics that define a worse disease prognosis or "high tumor burden" (HTB) status is essential for clinical decision-making and…”
Get full text

Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database by Campos‐Balea, Begoña, Castro Carpeño, Javier, Massutí, Bartomeu, Vicente‐Baz, David, Pérez Parente, Diego, Ruiz‐Gracia, Pedro, Crama, Leonardo, Cobo Dols, Manuel

“…Background Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of this study was to identify poor prognostic factors for…”
Get full text

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis by García-González, Jorge, Ruiz-Bañobre, Juan, Afonso-Afonso, Francisco J, Amenedo-Gancedo, Margarita, Areses-Manrique, María Del Carmen, Campos-Balea, Begoña, Casal-Rubio, Joaquín, Fernández-Núñez, Natalia, Fírvida Pérez, José Luis, Lázaro-Quintela, Martín, Pérez Parente, Diego, Crama, Leonardo, Ruiz-Gracia, Pedro, Santomé-Couto, Lucía, León-Mateos, Luis

“…The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option…”
Get full text

PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis by García Campelo, María Rosario, Arriola, Edurne, Campos Balea, Begoña, López-Brea, Marta, Fuentes-Pradera, José, de Castro Carpeno, Javier, Aguado, Carlos, Pérez Parente, Diego, de Oro Pulido, Fidel, Ruiz-Gracia, Pedro, Rodríguez-Abreu, Delvys

“…This network meta-analysis (NMA) evaluates the safety of first-line programmed death-ligand 1 (PD-L1) inhibitor monotherapy in advanced NSCLC patients compared…”
Get full text

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy by Pérez-Parente, Diego, Suárez-Ordóñez, Sandra, Suárez-Santamaría, Marta, Morano-Amado, Luis E

Get full text

Practical Issues in the Use of Atezolizumab for Patients with Non-Small Cell Lung Cancer: Case Reports and Literature Review by Cobo, Manuel, Rodríguez-Abreu, Delvys, Pérez Parente, Diego, Ruiz Gracia, Pedro, González, Jorge G.

“…Atezolizumab is a monoclonal antibody targeting the programmed death ligand 1 (PD-L1) that was approved in 2017 in the USA and Europe for the second-line…”
Get full text

Identifying prognostic and predictive value of mutations associated with clinical outcomes in first line (1L) patients with advanced or metastatic non–small cell lung cancer (aNSCLC) by Perez Parente, Diego, Cobo-Dols, Manuel, Hasan, Haroon, Olson, Sara, Pal, Navdeep, Wilkinson, Samantha, La Orden Tévar, Beatriz, Pérez Fernández, Mar, Provencio-Pulla, Mariano

“…9047 Background: Whilst the impact of certain mutations on aNSCLC survival outcomes has been evaluated, real-world (rw) evidence on its predictive and…”
Get full text

Atezolizumab in first-line treatment of metastatic nonsquamous non-small cell lung cancer in the real-world setting by De Castro, Javier, Campos Balea, Begoña, Perez Parente, Diego, Polito, Letizia, Lawrance, Marcus, Ruiz Gracia, Pedro, Adler, Leah, Marina Arroyo, Marta, Socinski, Mark A.

“…Abstract only e21112 Background: The phase III IMpower150 study showed efficacy benefits with atezolizumab in combination with bevacizumab, carboplatin and…”
Get full text

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy by Pérez-Parente, Diego, Suárez-Ordóñez, Sandra, Suárez-Santamaría, Marta, Morano-Amado, Luis E.

Get full text

PD-(L)1 inhibitors as monotherapy for the first-line treatment of non-small cell lung cancer patients with high PD-L1 expression: A network meta-analysis by Majem, Margarita, Cobo, Manuel, Isla, Dolores, Marquez-Medina, Diego, Rodriguez-Abreu, Delvys, Casal Rubio, Joaquín, Moran Bueno, Teresa, Bernabe Caro, Reyes, Perez Parente, Diego, Ruiz Gracia, Pedro, Marina Arroyo, Marta, Paz-Ares, Luis G.

“…Abstract only 9076 Background: PD-L1 has emerged as a potential biomarker for predicting responses to immunotherapy and as a prognostic factor in non-small…”
Get full text

Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy by Pérez-Parente, Diego, Suárez-Ordóñez, Sandra, Suárez-Santamaría, Marta, Morano-Amado, Luis E

Get full text